BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference

  November 5, 2024

   · 

  1 min read
• Press Releases

  Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights

  November 5, 2024

   · 

  7 min read
• Press Releases

  BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  November 5, 2024

   · 

  1 min read
• Press Releases

  TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance

  November 5, 2024

   · 

  3 min read
• Press Releases

  Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast

  November 5, 2024

   · 

  1 min read
• Press Releases

  ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistance and Type 2 Diabetes

  November 5, 2024

   · 

  6 min read
• Press Releases

  Entrada Therapeutics Reports Third Quarter 2024 Financial Results

  November 5, 2024

   · 

  10 min read
• Press Releases

  Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia

  November 5, 2024

   · 

  10 min read
• Press Releases

  NeuroMetrix Reports Q3 2024 Business Highlights

  November 5, 2024

   · 

  5 min read
• Press Releases

  AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

  November 5, 2024

   · 

  11 min read